Trial Profile
Phase II Trial of LBH589 [panobinostat] in Refractory Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 16 Jan 2012 Actual patient number (29) added as reported by ClinicalTrials.gov.
- 16 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.